US FDA informs public about possible accuracy concerns with Abbott ID NOW point-of-care test

Early data suggest the test may potentially return false negative results. Any negative test results that are not consistent with a patient’s clinical signs and symptoms or necessary for patient management should be confirmed with another test. Further investigations are ongoing.


US Food and Drug Administration